Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Purchased by JPMorgan Chase & Co.

JPMorgan Chase & Co. grew its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 10.6% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 69,411 shares of the medical instruments supplier's stock after purchasing an additional 6,645 shares during the period. JPMorgan Chase & Co. owned approximately 2.05% of Utah Medical Products worth $4,644,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in UTMD. Hotchkis & Wiley Capital Management LLC boosted its holdings in Utah Medical Products by 128.3% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 89,010 shares of the medical instruments supplier's stock valued at $5,956,000 after purchasing an additional 50,030 shares during the last quarter. Brandes Investment Partners LP boosted its stake in shares of Utah Medical Products by 66.2% during the 2nd quarter. Brandes Investment Partners LP now owns 116,524 shares of the medical instruments supplier's stock valued at $7,789,000 after buying an additional 46,427 shares during the last quarter. Minerva Advisors LLC increased its stake in shares of Utah Medical Products by 461.8% in the third quarter. Minerva Advisors LLC now owns 42,328 shares of the medical instruments supplier's stock worth $2,818,000 after buying an additional 34,794 shares during the last quarter. Rice Hall James & Associates LLC increased its stake in shares of Utah Medical Products by 24.3% in the third quarter. Rice Hall James & Associates LLC now owns 83,338 shares of the medical instruments supplier's stock worth $5,576,000 after buying an additional 16,297 shares during the last quarter. Finally, Bank of Montreal Can acquired a new stake in Utah Medical Products in the second quarter valued at $1,039,000. 69.60% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Utah Medical Products from a "strong-buy" rating to a "buy" rating in a research report on Thursday, November 7th.

Utah Medical Products Stock Up 0.3 %

NASDAQ:UTMD traded up $0.17 during trading hours on Friday, reaching $62.16. 15,702 shares of the stock were exchanged, compared to its average volume of 18,290. The stock has a market capitalization of $210.72 million, a P/E ratio of 14.56 and a beta of 0.09. The firm has a 50 day simple moving average of $63.32 and a 200-day simple moving average of $65.80. Utah Medical Products, Inc. has a 52 week low of $60.08 and a 52 week high of $84.10.

Utah Medical Products Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 3rd. Shareholders of record on Monday, December 16th were paid a dividend of $0.305 per share. This is a positive change from Utah Medical Products's previous quarterly dividend of $0.30. The ex-dividend date was Monday, December 16th. This represents a $1.22 annualized dividend and a yield of 1.96%. Utah Medical Products's payout ratio is presently 28.57%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.